A new hope for precision medicine.
Where this comes from
- Record sourced from PubMed, PMID 24154598.
- Also identified by DOI 10.1126/scitranslmed.3007622.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The SS1P immunotoxin is combined with immunomodulatory therapy in order to improve its efficacy in human mesothelioma (Hassan et al., this issue).
Medical subject headings
- Antibodies, Monoclonal
- GPI-Linked Proteins
- Immunosuppression Therapy
- Mesothelioma
- Peritoneal Neoplasms